Pricing Log in Create free account

Annovis Bio, Inc. (ANVS) vs BRIACELL THERAP (BCTX)

Annovis Bio, Inc. and BRIACELL THERAP are both Biotechnology companies. Annovis Bio, Inc. and BRIACELL THERAP are of similar size ($28.6M and $28.6M). Across the 7 metrics below, BRIACELL THERAP leads on 5 and Annovis Bio, Inc. on 2.

Valuation

Metric ANVS BCTX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 1.29 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.01 0.66
EV/Sales n/m n/m 9.02
Earnings yield (218.29%) (174.34%) (32.88%)
Free cash flow yield (140.87%) (145.86%) (23.13%)

Profitability

Metric ANVS BCTX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (703.68%) (212.23%) (51.96%)
Return on assets (227.74%) (154.34%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANVS BCTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 39.39% 88.66% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANVS BCTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.47 2.76 4.97
Net debt to EBITDA 0.66 0.57 1.01

Dividend

Metric ANVS BCTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ANVS BCTX Biotechnology median
Market cap 28.55m 28.55m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack